Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults

American Journal of Gastroenterology

Volumn 107, Issue 12, 2012, Pages 1852-1858

  Kwon, Young Min ^a   Oh, Seung Won ^b   Hwang, Seung Sik ^c   Lee, Cheolmin ^b   Kwon, Hygbrtae ^b   Chung, Goh Eun ^b  

^a Samyook Medical Center   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Inha University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SOUTH KOREA; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, HDL; FATTY LIVER; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREDICTIVE VALUE OF TESTS; PREVALENCE; QUESTIONNAIRES; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES;

EID: 84870855668     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.314     Document Type: Article

References (37)

1. Ludwig J, Viggiano TR, McGill DB et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-8.
2. Matteoni CA, Younossi ZM, Gramlich T et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413.
3. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-31.
4. Younossi ZM, Diehl AM, Ong JP. Nonalcoholic fatty liver disease: an agenda for clinical research. Hepatology 2002; 35: 746-52.
5. Omagari K, Kadokawa Y, Masuda J et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol 2002; 17: 1098-105.
6. Shen L, Fan JG, Shao Y et al. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J Gastroenterol 2003; 9: 1106-10.
7. Park SH, Jeon WK, Kim SH et al. Prevalence and risk factors of nonalcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 2006; 21: 138-43.
8. Seo SH, Lee HW, Park HW et al. Prevalence and associated factors of nonalcoholic fatty liver disease in the health screen examinees. Korean J Med 2006; 70: 26-32.
9. Lee JY, Kim KM, Lee SG et al. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol 2007; 47: 239-44.
10. Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2003; 124: 71-9.
11. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 2010; 51: 679-89.
12. Kim HJ, Kim HJ, Lee KE et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 2004; 164: 2169-75.
13. Sinn DH, Gwak GY, Park HN et al. Ultrasonographically detected nonalcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged asian adults. Am J Gastroenterol 2012; 107: 561-7.
14. Musso G, Gambino R, Bo S et al. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. Diabetes Care 2008; 31: 562-8.
15. Saadeh S, Younossi ZM, Remer EM et al. Th e utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-50.
16. International Diabetes Federation. Worldwide Definition of the Metabolic Syndrome. Available at: http://www. idf. org/webdata/docs/IDF-Metasyndrome- definition. pdf accessed 24 August, 2005.
17. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
18. Esteghamati A, Ashraf H, Khalilzadeh O et al. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of noncommunicable diseases in Iran (SuRFNCD-2007). Nutr Metab 2010; 7: 26.
19. Lee S, Choi S, Kim HJ et al. Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. J Korean Med Sci 2006; 21: 695-700.
20. Patel K, Th ompson A, Chuang W et al. Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients. J Gastroenterol Hepatol 2011; 26: 1182-8.
21. International Obesity Task Force (on behalf of the Steering Committee). Th e Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Western Pacific Region. Health Communications Australia Pty Limited: Sydney, Australia, 2002.
22. Adams LA, Lymp JF, St Sauver J et al. Th e natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129: 113-21.
23. Matteoni CA, Younossi ZM, Gramlich T et al. Non-alcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-9.
24. Sung KC, Ryan MC, Wilson AM. Th e severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects. Atherosclerosis 2009; 203: 581-6.
25. van der Poorten D, Milner KL, Hui J et al. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 2008; 48: 449-57.
26. Conus F, Allison DB, Rabasa-Lhoret R et al. Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J Clin Endocrinol Metab 2004; 89: 5013-20.
27. Katsuki A, Sumida Y, Urakawa H et al. Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care 2003; 26: 2341-4.
28. Wingaard T, Jacobsen BK. Lifestyle factors and incident metabolic syndrome. Th e Tromso Study 1979-2001. Diabetes Res Clin Pract 2007; 78: 217-24.
29. Panagiotakos DB, Pitsavos C, Skoumas Y et al. The association between food patterns and the metabolic syndrome using principal components analysis: The ATTICA Study. J Am Diet Assoc 2007; 107: 979-87.
30. Laaksonen DE, Lakka HM, Salonen JT et al. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care 2002; 25: 1612-8.
31. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37: 1202-19.
32. Choi J, Se-Young O, Lee D et al. Characteristics of diet patterns in metabolically obese, normal weight adults (Korean National Health and Nutrition Examination Survey III, 2005). Nutr Metab Cardiovasc Dis 2012; 22: 567-74.
33. V ö lzke H, Schwarz S, Baumeister SE et al. Menopausal status and hepatic steatosis in a general female population. Gut 2007; 56: 594-5.
34. Saphner T, Triest-Robertson S, Li H et al. The association of non alcoholic steatohepatitis and tamoxifen in patients with breast cancer. Cancer 2009; 115: 3189-95.
35. Cerda C, P é rez-Ayuso RM, Riquelme A et al. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. J Hepatol 2007; 47: 412-7.
36. Mehta SR, Th omas EL, Bell JD et al. Non-invasive means of measuring hepatic fat content. World J Gastroenterol 2008; 14: 3476-83.
37. Palmentieri B, de Sio I, La Mura V et al. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis 2006; 38: 485-9.